ArticleFrontiers in research metrics and analytics2026
Strategic decoupling between grant and publication language in AI and cancer research: a cross-national LLM-assisted analysis.
Article in Frontiers in research metrics and analytics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Funding systems increasingly reward scientists who frame technical questions as narratives of national priority and societal impact, yet whether this policy-facing language carries through to how science is actually reported, or merely serves as a temporary rhetorical layer for grant competition, remains unclear. Using Google Gemini as a large language model-assisted text-analytic tool, we scored 400 matched pairs of funded grant abstracts and their linked peer-reviewed publications from China and the United States, across two contrasting fields: artificial intelligence and cancer immunology. Each text was scored 1-10 for macro-narrative ("hype") language and for mechanistic scientific logic, and a blinded 20% subset rated by two human raters showed broad agreement with the model-based scores. Funding language differed more by field than by country: artificial intelligence grants in both nations showed substantially higher policy-facing rhetoric than cancer immunology grants, which remained anchored in mechanistic logic. This rhetorical inflation, however, largely disappeared at the publication stage, where macro-narrative scores dropped sharply across both countries and disciplines-a grant-to-publication shift we term strategic textual decoupling. These findings suggest that funding systems may encourage rhetorical compliance without necessarily improving the scientific record, and that the gap between the language required to win funding and the language used to communicate science represents a hidden cognitive tax. Reducing unnecessary narrative inflation in grant evaluation, and tailoring assessment to disciplinary realities, could improve research integrity and the efficient use of researchers' time.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.